← SkinHealth Systems Inc.

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Net Income — — — $44.2m ($100.1m) ($29.1m) ($9.5m)
Net Income From Continuing Operations — — — $44.2m ($100.1m) ($29.1m) ($9.5m)
Amortization of intangible assets $12.5m $11.8m $13.3m $14.9m $20.9m $19.5m $17.0m
Depreciation of property and equipment $1.4m $2.6m $4.5m $7.2m $11.3m $9.9m $3.8m
Amortization of other assets $63k $132k $147k $857k $2.4m $4.2m $4.5m
Amortization of debt issuance costs — — $4.1m $4.2m $4.2m $3.3m $3.6m
Amortization Cash Flow — — — $15.7m $23.3m $23.7m $21.5m
Amortization Of Intangibles — — — $15.7m $23.3m $23.7m $21.5m
Depreciation — — — $7.2m $11.3m $9.9m $3.8m
Depreciation Amortization Depletion — — — $22.9m $34.7m $33.7m $25.3m
Deferred income taxes — — — ($1.8m) ($1.1m) ($3.7m) $2.2m
Deferred Income Tax — — — ($1.8m) ($1.1m) ($3.7m) $2.2m
Deferred Tax — — — ($1.8m) ($1.1m) ($3.7m) $2.2m
Share-based compensation $103k $363k $12.4m $28.5m $22.5m $26.7m $14.8m
Asset Impairment Charge — — — $5.1m $37.8m $28.0m $7.2m
Accounts payable, accrued expenses, and income tax payable — — — ($3.0m) $44.0m ($43.8m) ($7.2m)
Net loss ($1.6m) ($1.1m) ($375.1m) $44.4m ($100.1m) ($29.1m) ($9.5m)
Inventory write-down — — $1.1m $5.1m $18.3m $28.0m $7.2m
Syndeo inventory write-down — — $0 $0 $19.6m $0 $0
Provision for estimated credit losses $659k $1.4m $854k $1.6m $5.2m $5.1m $2.1m
Change in fair value of warrant liabilities $0 $0 $277.3m ($78.3m) ($11.9m) ($3.1m) ($487k)
Gain on exchange and repurchases of convertible senior notes, net — — — $0 $0 ($33.4m) ($18.1m)
Other, net — — $0 ($4.3m) $0 ($302k) $0
Accounts receivable ($11.0m) $3.7m ($31.0m) ($32.0m) $16.5m $20.8m $5.2m
Inventories ($4.8m) ($3.2m) ($9.4m) ($82.1m) ($22.6m) ($10.5m) $15.8m
Cash paid for intangible assets ($1.6m) ($316k) ($4.4m) ($6.5m) ($9.2m) ($6.0m) ($4.9m)
Cash paid for property and equipment ($8.8m) ($3.5m) ($11.2m) ($10.8m) ($3.8m) ($756k) ($303k)
Cash paid for asset acquisitions — $0 $0 ($1.5m) ($18.5m) $0 $0
Repurchase of 2026 Notes in connection with exchange — — — — $0 $0 ($392.6m)
Issuance of 2028 Notes in connection with exchange, net $0 $0 $750.0m $0 $0 $0 $237.6m
Repurchase of 2026 Notes — — — $0 $0 ($156.1m) ($18.4m)
Payment of tax withholdings on vested stock awards — $0 $0 ($927k) ($3.2m) ($2.0m) ($1.6m)
Payment of accelerated share repurchases — — $0 $0 ($2.2m) $0 $0
Payment of contingent considerations related to acquisitions $0 ($901k) $0 ($4.3m) ($1.8m) $0 $0
Effect of foreign currency translation on cash ($94k) $159k ($543k) ($3.0m) $2.0m ($4.0m) $5.2m
Beginning Cash Position — — — $901.9m $568.2m $523.0m $370.1m
Cash Flow From Continuing Financing Activities — — — ($205.2m) ($37.4m) ($158.3m) ($174.9m)
Cash Flow From Continuing Investing Activities — — — ($18.9m) ($31.5m) ($6.8m) ($5.2m)
Change In Account Payable — — $10.5m $1.6m $15.8m — —
Change In Accrued Expense — — $24.8m ($3.4m) $26.9m — —
Change In Income Tax Payable — — ($594k) $198k $1.3m — —
Change In Inventory — — — ($84.4m) ($22.6m) ($10.5m) $15.8m
Change In Other Current Assets — — ($6.1m) ($8.0m) — — —
Change In Other Current Liabilities — — ($1.4m) ($4.0m) — — —
Change In Other Working Capital — — — ($12.1m) ($7.6m) ($9.4m) ($6.8m)
Change In Payable — — $9.9m $1.8m $17.1m — —
Change In Payables And Accrued Expense — — — ($3.0m) $44.0m ($43.8m) ($7.2m)
Change In Prepaid Assets — — — ($13.8m) ($7.0m) $15.5m $3.4m
Change In Receivables — — — ($32.0m) $16.5m $20.8m $5.2m
Change In Tax Payable — — ($594k) $198k $1.3m — —
Change In Working Capital — — — ($145.3m) $23.4m ($27.4m) $10.4m
Changes In Account Receivables — — — ($32.0m) $16.5m $20.8m $5.2m
Changes In Cash — — — ($330.7m) ($47.2m) ($149.0m) ($142.6m)
End Cash Position — — — $568.2m $523.0m $370.1m $232.7m
Financing Cash Flow — — — ($205.2m) ($37.4m) ($158.3m) ($174.9m)
Free Cash Flow — — — ($124.0m) $8.7m $9.3m $32.3m
Gain Loss On Investment Securities — — — ($78.3m) ($11.9m) ($3.1m) ($487k)
Gain Loss On Sale Of PPE — — $0 $5.2m — — —
Investing Cash Flow — — — ($18.9m) ($31.5m) ($6.8m) ($5.2m)
Net Business Purchase And Sale — — ($22.9m) $0 $0 — —
Net Foreign Currency Exchange Gain Loss — — $0 $2.4m — — —
Net Intangibles Purchase And Sale — — — ($6.5m) ($9.2m) ($6.0m) ($4.9m)
Net PPE Purchase And Sale — — — ($10.8m) ($3.8m) ($756k) ($303k)
Operating Gains Losses — — — ($78.3m) ($11.9m) ($3.1m) ($487k)
Other Non Cash Items — — — $16.4m $11.3m ($14.1m) ($14.6m)
Proceeds From Stock Option Exercised — — $188.4m $0 $0 — —
Provisionand Write Offof Assets — — — $1.6m $5.2m $5.1m $2.1m
Purchase Of Business — — ($22.9m) $0 $0 — —
Purchase Of Intangibles — — — ($6.5m) ($9.2m) ($6.0m) ($4.9m)
Purchase Of PPE — — $11.2m ($10.8m) ($3.8m) ($756k) ($303k)
Repurchase Of Capital Stock — — — ($160.0m) ($32.4m) $0 $0
Stock Based Compensation — — — $28.5m $22.5m $26.7m $14.8m
Net cash provided by operating activities $1.7m ($12.4m) ($28.4m) ($106.6m) $21.8m $16.1m $37.5m
Capital Expenditure — — — ($17.4m) ($13.0m) ($6.8m) ($5.2m)
Capital Expenditure Reported — — ($15.6m) ($17.4m) — — —
Net Other Investing Changes — — $781k ($1.5m) ($18.5m) — —
Net cash used for investing activities ($12.5m) ($3.8m) ($37.7m) ($18.9m) ($31.5m) ($6.8m) ($5.2m)
Issuance Of Debt — — — $0 $0 $0 $237.6m
Long Term Debt Issuance — — — $0 $0 $0 $237.6m
Net Issuance Payments Of Debt — — — $0 $0 ($156.1m) ($173.4m)
Net Long Term Debt Issuance — — — $0 $0 ($156.1m) ($173.4m)
Net Short Term Debt Issuance — — $0 $0 $0 — —
Short Term Debt Issuance — — $5.0m $0 $0 — —
Long Term Debt Payments — — — $0 $0 ($156.1m) ($411.0m)
Repayment Of Debt — — — $0 $0 ($156.1m) ($411.0m)
Short Term Debt Payments — — ($5.0m) $0 $0 — —
Class A Common Stock issued for asset acquisition — — $0 $500k $1.3m $0 $0
Net Common Stock Issuance — — — ($160.0m) ($32.4m) $0 $0
Repurchase of common stock $0 ($154k) $0 ($160.0m) ($30.2m) $0 $0
Common Stock Payments — — — ($160.0m) ($32.4m) $0 $0
Net Other Financing Charges — — — ($45.2m) ($5.1m) ($2.3m) ($1.6m)
Net cash used for financing activities $14.6m $18.3m $959.0m ($205.2m) ($37.4m) ($158.3m) ($174.9m)
Effect Of Exchange Rate Changes — — — ($3.0m) $2.0m ($4.0m) $5.2m
Net change in cash, cash equivalents, and restricted cash $3.8m $2.0m $892.9m ($330.7m) ($47.2m) ($149.0m) ($142.6m)
Cash, cash equivalents, and restricted cash beginning of period $7.3m $9.5m $901.9m $568.2m $523.0m $370.1m $232.7m
Change In Cash Supplemental As Reported — — — ($330.7m) ($47.2m) ($149.0m) ($142.6m)
Cash paid for interest $15.7m $13.5m $10.2m $9.8m $9.4m $8.0m $14.4m
Prepaid expenses, other current assets, and income tax receivable ($1.1m) $489k ($5.4m) ($16.4m) ($3.3m) $15.5m $3.4m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.